Corticotropin releasing factor: A key role in the neurobiology of addiction
Open accessThe DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
Abstract
Drug addiction is a chronically relapsing disorder characterized by loss of control over intake and dysregulation of stress-related brain emotional systems. Since the discovery by Wylie Vale and his colleagues of corticotropin-releasing factor (CRF) and the structurally-related urocortins, CRF systems have emerged as mediators of the body’s response to stress. Relatedly, CRF systems have a prominent role in driving addiction via actions in the central extended amygdala, producing anxiety-like behavior, reward deficits, excessive, compulsive-like drug self-administration and stress-induced reinstatement of drug seeking. CRF neuron activation in the medial prefrontal cortex may also contribute to the loss of control. Polymorphisms in CRF system molecules are associated with drug use phenotypes in humans, often in interaction with stress history. Drug discovery efforts have yielded brain-penetrant CRF1 antagonists with activity in preclinical models of addiction.. The results support the hypothesis that brain CRF-CRF1 systems contribute to the etiology and maintenance of addiction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · cited 1×
“Since the successive discovery by Wylie Vale and his colleagues of corticotropin-releasing factor (CRF) (Vale et al., 1981), the structurally-related urocortins (Ucn 1, Ucn 2, Ucn 3), and their cognate receptors (CRF1, CRF2) (Bale and Vale, 2004; Fekete and Zorrilla, 2007), CRF systems have emerged…”
BackgroundVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Self-citationCellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Self-citationSwanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953
An opponent-process theory of motivation. I. Temporal dynamics of affect
Solomon, R. L., & Corbit, J. D. (1974) · Psychological Review · doi:10.1037/h0036128 · Cited by 1,704
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
Vaughan, J., Donaldson, C., Bittencourt, J., Perrin, M. H., Lewis, K., Sutton, S., Chan, R., Turnbull, A. V., Lovejoy, D., Rivier, C., et al. (1995) · Nature · doi:10.1038/378287a0 · Cited by 1,479
CRF and CRF receptors: role in stress responsivity and other behaviors
Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270
A Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056 · cited 1×
“…bases for stress-induced reinstatement as contrasted from overlapping, but distinct, neurocircuits that differentially subserve drug prime- or drug cue- (discrete, discriminative or contextual) induced reinstatement (see Koob, 2008; Steketee and Kalivas, 2011; Bossert et al., 2013 for reviews).”
BackgroundSelf-citationChalmers, D., Lovenberg, T., & De Souza, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06340.1995 · Cited by 919
Corticotropin releasing factor produces behavioural activation in rats
Sutton, R. E., Koob, G. F., Le Moal, M., Rivier, J., & Vale, W. (1982) · Nature · doi:10.1038/297331a0 · Cited by 754
Self-citationDrug Wanting: Behavioral Sensitization and Relapse to Drug-Seeking Behavior
Steketee, J. D., & Kalivas, P. W. (2011) · Pharmacological Reviews · doi:10.1124/pr.109.001933 · Cited by 650
Intermittent Access to 20% Ethanol Induces High Ethanol Consumption in Long–Evans and Wistar Rats
Simms, J. A., Steensland, P., Medina, B., Abernathy, K. E., Chandler, L. J., Wise, R., & Bartlett, S. E. (2008) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00753.x · Cited by 610
Noradrenergic mechanisms in stress and anxiety: I. preclinical studies
Bremner, J. D., Krystal, J. H., Southwick, S. M., & Charney, D. S. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199605)23:1<28::aid-syn4>3.0.co;2-j · Cited by 594
Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565 · cited 1×
“For example, in dependent rat models, acute alcohol withdrawal activates CRF systems in the central nucleus of the amygdala (CeA) (Merlo Pich et al., 1995; Zorrilla et al., 2001; Funk et al., 2006; Roberto et al., 2010) and bed nucleus of the stria terminalis (Olive et al., 2002).”
BackgroundSelf-citationAppetite-Suppressing Effects of Urocortin, a CRF-Related Neuropeptide
Spina, M., Merlo-Pich, E., Chan, R. K. W., Basso, A. M., Rivier, J., Vale, W., & Koob, G. F. (1996) · Science · doi:10.1126/science.273.5281.1561 · Cited by 564
Self-citationA key role for corticotropin-releasing factor in alcohol dependence
Heilig, M., & Koob, G. F. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.006 · Cited by 503 · cited 8×
“Under this conceptualization of addiction, substance abuse escalates because the drug of abuse mitigates the counter-regulatory negative emotional symptoms of acute and protracted withdrawal (Heilig and Koob, 2007; Koob and Zorrilla, 2010; Zorrilla et al., 2013a).”
BackgroundInfluentialSelf-citationActivation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal
Rodrı́guez de Fonseca, F., Carrera, M. R. A., Navarro, M., Koob, G. F., & Weiss, F. (1997) · Science · doi:10.1126/science.276.5321.2050 · Cited by 499 · cited 1×
“…response that can be reversed by intracranial administration of non-selective peptide CRF receptor antagonists (Sarnyai et al., 1995; Rodriguez de Fonseca et al., 1997; Basso et al., 1999; Tucci et al., 2003) or systemic administration of brain-penetrant CRF1selective nonpeptide…”
BackgroundSelf-citationAlcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men.
Cooney, N. L., Litt, M. D., Morse, P. A., Bauer, L. O., & Gaupp, L. (1997) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.106.2.243 · Cited by 479 · cited 1×
“Exposure to external stressors can also increase drug craving (Childress et al., 1994; Cooney et al., 1997; Sinha et al., 2000) and lead to relapse.”
BackgroundRole of Corticotropin-Releasing Factor in Drug Addiction: Potential for Pharmacological Intervention
Logrip, M. L., Koob, G. F., & Zorrilla, E. P. (2011) · CNS Drugs · doi:10.2165/11587790-000000000-00000 · Cited by 476
Self-citationPsychological stress, drug-related cues and cocaine craving
Sinha, R., Fuse, T., Aubin, L.-R., & O'Malley, S. S. (2000) · Psychopharmacology · doi:10.1007/s002130000499 · Cited by 463 · cited 1×
“Exposure to external stressors can also increase drug craving (Childress et al., 1994; Cooney et al., 1997; Sinha et al., 2000) and lead to relapse.”
BackgroundBossert, J. M., Marchant, N. J., Calu, D. J., & Shaham, Y. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3120-y · Cited by 453
REVIEW: Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked?
Heilig, M., Egli, M., Crabbe, J. C., & Becker, H. C. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00194.x · Cited by 435 · cited 3×
“…downregulation of brain reward systems (e.g., ventral striatum) and upregulation of brain stress systems, including CRF and norepinephrine systems in the extended amygdala (Heilig and Koob, 2007; Heilig et al., 2010a,b, 2011; Koob and Zorrilla, 2010, 2012; Breese et al., 2011; Logrip et al., 2011).”
BackgroundCompulsive Drug‐Seeking Behavior and Relapse: Neuroadaptation, Stress, and Conditioning Factors
WEISS, F., CICCOCIOPPO, R., PARSONS, L. H., KATNER, S., LIU, X., ZORRILLA, E. P., VALDEZ, G. R., BEN‐SHAHAR, O., ANGELETTI, S., & RICHTER, R. R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03556.x · Cited by 430
Self-citationNew findings on biological factors predicting addiction relapse vulnerability
Sinha, R. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0224-0 · Cited by 401
Valdez, G. R., Roberts, A. J., Chan, K., Davis, H., Brennan, M., Zorrilla, E. P., & Koob, G. F. (2002) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02448.x · Cited by 387
Self-citationHolsboer, F., & Ising, M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.032 · Cited by 382
Voluntary ethanol intake in rats following exposure to ethanol on various schedules
Wise, R. A. (1973) · Psychopharmacologia · doi:10.1007/bf00414034 · Cited by 382
Funk, C. K., O'Dell, L. E., Crawford, E. F., & Koob, G. F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3096-06.2006 · Cited by 381
Self-citationWang, B., Shaham, Y., Zitzman, D., Azari, S., Wise, R. A., & You, Z.-B. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0955-05.2005 · Cited by 369
Liu, X., & Weiss, F. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-18-07856.2002 · Cited by 359
Potter, E., Behan, D. P., Fischer, W. H., Linton, E. A., Lowry, P. J., & Vale, W. W. (1991) · Nature · doi:10.1038/349423a0 · Cited by 358
Stress and Alcohol Interaction: An Update of Human Research
Pohorecky, L. A. (1991) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1991.tb00543.x · Cited by 344
Roberto, M., Cruz, M. T., Gilpin, N. W., Sabino, V., Schweitzer, P., Bajo, M., Cottone, P., Madamba, S. G., Stouffer, D. G., Zorrilla, E. P., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.11.007 · Cited by 336
Self-citationErb, S., Shaham, Y., & Stewart, J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05529.1998 · Cited by 329
Rimondini, R., Arlinde, C., Sommer, W., & Heilig, M. (2002) · The FASEB Journal · doi:10.1096/fj.01-0593com · Cited by 321
Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats
Vendruscolo, L. F., Barbier, E., Schlosburg, J. E., Misra, K. K., Whitfield, T. W., Logrip, M. L., Rivier, C., Repunte-Canonigo, V., Zorrilla, E. P., Sanna, P. P., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0069-12.2012 · Cited by 319
Self-citationLê, A. D., Harding, S., Juzytsch, W., Watchus, J., Shalev, U., & Shaham, Y. (2000) · Psychopharmacology · doi:10.1007/s002130000411 · Cited by 310
Sommer, W. H., Rimondini, R., Hansson, A. C., Hipskind, P. A., Gehlert, D. R., Barr, C. S., & Heilig, M. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.010 · Cited by 309
Shaham, Y., Funk, D., Erb, S., Brown, T. J., Walker, C.-D., & Stewart, J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02605.1997 · Cited by 308
Shaham, Y., Erb, S., Leung, S., Buczek, Y., & Stewart, J. (1998) · Psychopharmacology · doi:10.1007/s002130050608 · Cited by 302
The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse
Shepard, J. D., Bossert, J. M., Liu, S. Y., & Shaham, Y. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.032 · Cited by 294
Potter, E., Behan, D. P., Linton, E. A., Lowry, P. J., Sawchenko, P. E., & Vale, W. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4192 · Cited by 285
Noradrenergic mechanisms in stress and anxiety: II. Clinical studies
Bremner, J. D., Krystal, J. H., Southwick, S. M., & Charney, D. S. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199605)23:1<39::aid-syn5>3.0.co;2-i · Cited by 278
Funk, C. K., Zorrilla, E. P., Lee, M.-J., Rice, K. C., & Koob, G. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.063 · Cited by 276
Self-citationLu, L., Shepard, J. D., Scott Hall, F., & Shaham, Y. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00073-3 · Cited by 276
Breese, G. R., Sinha, R., & Heilig, M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.007 · Cited by 261
The dark side of food addiction
Parylak, S. L., Koob, G. F., & Zorrilla, E. P. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.04.063 · Cited by 257
Self-citationDistribution of urocortin-like immunoreactivity in the central nervous system of the rat
Kozicz, T., Yanaihara, H., & Arimura, A. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980202)391:1<1::aid-cne1>3.0.co;2-6 · Cited by 256
Sarnyai, Z., Bíró, É., Gardi, J., Vecsernyés, M., Julesz, J., & Telegdy, G. (1995) · Brain Research · doi:10.1016/0006-8993(95)00043-p · Cited by 255 · cited 2×
“…produces an anxiogenic-like response that can be reversed by intracranial administration of non-selective peptide CRF receptor antagonists (Sarnyai et al., 1995; Rodriguez de Fonseca et al., 1997; Basso et al., 1999; Tucci et al., 2003) or systemic administration of brain-penetrant…”
BackgroundHansson, A. C., Cippitelli, A., Sommer, W. H., Fedeli, A., Björk, K., Soverchia, L., Terasmaa, A., Massi, M., Heilig, M., & Ciccocioppo, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604419103 · Cited by 249
Pharmacogenetic approaches to the treatment of alcohol addiction
Heilig, M., Goldman, D., Berrettini, W., & O'Brien, C. P. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3110 · Cited by 248
Zorrilla, E., Valdez, G., & Weiss, F. (2001) · Psychopharmacology · doi:10.1007/s002130100773 · Cited by 246
Self-citationGeorge, O., Ghozland, S., Azar, M. R., Cottone, P., Zorrilla, E. P., Parsons, L. H., O'Dell, L. E., Richardson, H. N., & Koob, G. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707585104 · Cited by 245 · cited 6×
“, 2008), nicotine (George et al., 2007), and heroin (Greenwell et al.”
BackgroundInfluentialSelf-citationCorticotropin Releasing Factor (CRF) Binding Protein: A Novel Regulator of CRF and Related Peptides
Behan, D. P., De Souza, E. B., Lowry, P. J., Potter, E., Sawchenko, P., & Vale, W. W. (1995) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1995.1013 · Cited by 243
Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: Ancient CRF paralogs
Fekete, É. M., & Zorrilla, E. P. (2007) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2006.09.002 · Cited by 243
Self-citationGehlert, D. R., Cippitelli, A., Thorsell, A., Lê, A. D., Hipskind, P. A., Hamdouchi, C., Lu, J., Hembre, E. J., Cramer, J., Song, M., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4985-06.2007 · Cited by 239
George, O., Sanders, C., Freiling, J., Grigoryan, E., Vu, S., Allen, C. D., Crawford, E., Mandyam, C. D., & Koob, G. F. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116523109 · Cited by 238
Self-citationOlive, M. F., Koenig, H. N., Nannini, M. A., & Hodge, C. W. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00748-1 · Cited by 237
Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use
Blomeyer, D., Treutlein, J., Esser, G., Schmidt, M. H., Schumann, G., & Laucht, M. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.026 · Cited by 211 · cited 3×
“Stress history produces greater increases in future alcohol intake (Blomeyer et al., 2008; Schmid et al., 2010) and an earlier onset of drinking (Schmid et al.”
BackgroundRichter, R. M., & Weiss, F. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990615)32:4%3c254::aid-syn2%3e3.0.co;2-h · Cited by 207
Wang, B., You, Z.-B., Rice, K. C., & Wise, R. A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0782-3 · Cited by 207
CRF system recruitment mediates dark side of compulsive eating
Cottone, P., Sabino, V., Roberto, M., Bajo, M., Pockros, L., Frihauf, J. B., Fekete, E. M., Steardo, L., Rice, K. C., Grigoriadis, D. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908789106 · Cited by 192 · cited 1×
“Specifically, rats acutely withdrawn from intermittent access to a high-sucrose, chocolate-flavored diet showed increased anxiety-like behavior (Cottone et al., 2009).”
BackgroundSelf-citationMarinelli, P. W., Funk, D., Juzytsch, W., Harding, S., Rice, K. C., Shaham, Y., & Lê, A. D. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0905-x · Cited by 191
Basso, A. M., Spina, M., Rivier, J., Vale, W., & Koob, G. F. (1999) · Psychopharmacology · doi:10.1007/s002130051028 · Cited by 190
Self-citationValdez, G. R., Zorrilla, E. P., Roberts, A. J., & Koob, G. F. (2003) · Alcohol · doi:10.1016/s0741-8329(03)00020-x · Cited by 186
Self-citationTreutlein, J., Kissling, C., Frank, J., Wiemann, S., Dong, L., Depner, M., Saam, C., Lascorz, J., Soyka, M., Preuss, U. W., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001813 · Cited by 186 · cited 2×
“Several Crhr1 haplotype variants in adolescents predict binge drinking and lifetime prevalence of intoxication and alcohol dependence (Treutlein et al., 2006).”
BackgroundThe therapeutic potential of CRF1 antagonists for anxiety
Zorrilla, E. P., & Koob, G. F. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.7.799 · Cited by 176
Self-citationRole of CRF and other neuropeptides in stress-induced reinstatement of drug seeking
Shalev, U., Erb, S. M., & Shaham, Y. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.028 · Cited by 175
Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors
Overstreet, D. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.11.010 · Cited by 172
Can induced moods trigger drug-related responses in opiate abuse patients?
Childress, A. R., Ehrman, R., McLellan, A. T., MacRae, J., Natale, M., & O'Brien, C. P. (1994) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(94)90060-4 · Cited by 171 · cited 1×
“Exposure to external stressors can also increase drug craving (Childress et al., 1994; Cooney et al., 1997; Sinha et al., 2000) and lead to relapse.”
BackgroundGhitza, U. E., Gray, S. M., Epstein, D. H., Rice, K. C., & Shaham, Y. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300964 · Cited by 171
Chu, K., Koob, G. F., Cole, M., Zorrilla, E. P., & Roberts, A. J. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.03.009 · Cited by 170
Self-citationNeurobiological mechanisms of addiction: focus on corticotropin-releasing factor.
Koob, G. F., & Zorrilla, E. P. (2010) · PubMed · Cited by 167
Self-citationProgress in corticotropin-releasing factor-1 antagonist development
Zorrilla, E. P., & Koob, G. F. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.02.011 · Cited by 167
Self-citationConceptual framework for the etiology of alcoholism: a “kindling”/stress hypothesis
Breese, G. R., Overstreet, D. H., & Knapp, D. J. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2016-2 · Cited by 167
Ciccocioppo, R., Economidou, D., Cippitelli, A., Cucculelli, M., Ubaldi, M., Soverchia, L., Lourdusamy, A., & Massi, M. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00032.x · Cited by 166
George, O., Mandyam, C. D., Wee, S., & Koob, G. F. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301626 · Cited by 163
Self-citationAccentuated Decrease in Social Interaction in Rats Subjected to Repeated Ethanol Withdrawals
Overstreet, D. H., Knapp, D. J., & Breese, G. R. (2002) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02665.x · Cited by 160
Lee, B., Tiefenbacher, S., Platt, D. M., & Spealman, R. D. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300391 · Cited by 160
Autoradiographic Localization of CRF1 and CRF2 Binding Sites in Adult Rat Brain
Primus, R. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00071-7 · Cited by 158
Valdez, G. R., Inoue, K., Koob, G. F., Rivier, J., Vale, W., & Zorrilla, E. P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02707-5 · Cited by 158
Self-citationPlaza-Zabala, A., Martín-García, E., de Lecea, L., Maldonado, R., & Berrendero, F. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5724-09.2010 · Cited by 157
LOWMAN, C., ALLEN, J., STOUT, R. L., & THE RELAPSE RESEARCH GROUP (1996) · Addiction · doi:10.1111/j.1360-0443.1996.tb02327.x · Cited by 155
Valdez, G. R., Zorrilla, E. P., Rivier, J., Vale, W., & Koob, G. F. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02971-8 · Cited by 153
Self-citationLowery-Gionta, E. G., Navarro, M., Li, C., Pleil, K. E., Rinker, J. A., Cox, B. R., Sprow, G. M., Kash, T. L., & Thiele, T. E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6256-11.2012 · Cited by 149
Briand, L. A., Flagel, S. B., García-Fuster, M. J., Watson, S. J., Akil, H., Sarter, M. F., & Robinson, T. E. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.18 · Cited by 147
CRF1 receptor antagonists attenuate escalated cocaine self-administration in rats
Specio, S. E., Wee, S., O’Dell, L. E., Boutrel, B., Zorrilla, E. P., & Koob, G. F. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0983-9 · Cited by 145
Self-citationBachtell, R. K., Wang, Y., Freeman, P. A., Risinger, F. O., & Ryabinin, A. E. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02019-3 · Cited by 144
Stinus, L., Cador, M., Zorrilla, E. P., & Koob, G. F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300487 · Cited by 139 · cited 1×
“Furthermore, the aversive state of opiate withdrawal and the decreased brain reward function associated with nicotine withdrawal are both CRF1 receptor-dependent (Contarino and Papaleo, 2005; Stinus et al., 2005; Bruijnzeel et al., 2007, 2009, 2012; Garcia-Carmona et al., 2012).”
BackgroundSelf-citationAlcohol withdrawal symptoms and drinking behavior.
Hershon, H. I. (1977) · Journal of Studies on Alcohol · doi:10.15288/jsa.1977.38.953 · Cited by 139
Bruijnzeel, A. W., Prado, M., & Isaac, S. K. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.010 · Cited by 139
Lowery, E. G., Spanos, M., Navarro, M., Lyons, A. M., Hodge, C. W., & Thiele, T. E. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.209 · Cited by 137
Wang, J., Fang, Q., Liu, Z., & Lu, L. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0262-6 · Cited by 134 · cited 1×
“The results agree with other evidence that activation of extrahypothalamic CRF sites subserves stress-induced reinstatement behavior (Shaham et al., 1997; Erb et al., 1998; Wang et al., 2005, 2006; Blacktop et al., 2011).”
ResultAntagonism of CRF2 receptors produces anxiolytic behavior in animal models of anxiety
Takahashi, L. K., Ho, S. P., Livanov, V., Graciani, N., & Arneric, S. P. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02405-2 · Cited by 132 · cited 2×
“001 in this area, however, because pharmacological activation of CRF2 receptors has been found to decrease anxiety-like behavior, increase anxiety-like behavior, or not alter stress-related behavior, depending on the neuropharmacological probe, dose, and brain site (Ho et al., 2001; Takahashi et al., 2001; Fekete and…”
BackgroundValdez, G. R., Sabino, V., & Koob, G. F. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000128222.29875.40 · Cited by 131 · cited 2×
“…CRF2 agonist, reduced the heightened anxiety-like behavior and increased ethanol self-administration in dependent rats during acute withdrawal (Valdez et al., 2004) as well as the alcohol intake of mice that receive limited, binge-like access to alcohol (Sharpe and Phillips, 2009; Lowery et…”
BackgroundSelf-citationThe Role of Corticotropin-Releasing Factor in the Median Raphe Nucleus in Relapse to Alcohol
Lê, A. D., Harding, S., Juzytsch, W., Fletcher, P. J., & Shaham, Y. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-18-07844.2002 · Cited by 131
SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats
Knapp, D. J., Overstreet, D. H., Moy, S. S., & Breese, G. R. (2004) · Alcohol · doi:10.1016/j.alcohol.2003.08.007 · Cited by 130
Nicotine self-administration and reinstatement of nicotine-seeking in male and female rats
Feltenstein, M. W., Ghee, S. M., & See, R. E. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.09.001 · Cited by 126
Breese, G. R., Overstreet, D. H., Knapp, D. J., & Navarro, M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300706 · Cited by 124 · cited 2×
“…can also reduce the heightened anxiety-like behavior in dependent rodents acutely withdrawn from alcohol at doses that do not alter the anxiety-like behavior of non-dependent animals (Knapp et al., 2004; Overstreet et al., 2004; Breese et al., 2005a,b; Gehlert et al., 2007; Sommer et al., 2008).”
BackgroundKaur, S., & Ryabinin, A. E. (2010) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01237.x · Cited by 122
ZYWIAK, W. H., CONNORS, G. J., MAISTO, S. A., & WESTERBERG, V. S. (1996) · Addiction · doi:10.1111/j.1360-0443.1996.tb02332.x · Cited by 121
Zislis, G., Desai, T. V., Prado, M., Shah, H. P., & Bruijnzeel, A. W. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.09.007 · Cited by 120
Gilpin, N. W., Richardson, H. N., & Koob, G. F. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00745.x · Cited by 120
Self-citationTeegarden, S. L., Scott, A. N., & Bale, T. L. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.029 · Cited by 119
Contarino, A., & Papaleo, F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506999102 · Cited by 118
Heilig, M., Thorsell, A., Sommer, W. H., Hansson, A. C., Ramchandani, V. A., George, D. T., Hommer, D., & Barr, C. S. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.11.018 · Cited by 117
Logrip, M. L., Zorrilla, E. P., & Koob, G. F. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.007 · Cited by 117
Self-citationYohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients
Stine, S. M., Southwick, S. M., Petrakis, I. L., Kosten, T. R., Charney, D. S., & Krystal, J. H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01292-6 · Cited by 111
Bruijnzeel, A. W., Zislis, G., Wilson, C., & Gold, M. S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301192 · Cited by 110
Funk, C. K., & Koob, G. F. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.009 · Cited by 109
Self-citationZorrilla, E. P., Heilig, M., de Wit, H., & Shaham, Y. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.12.017 · Cited by 108
Self-citationSabino, V., Cottone, P., Koob, G. F., Steardo, L., Lee, M. J., Rice, K. C., & Zorrilla, E. P. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0546-5 · Cited by 108
Self-citationThe Edinger-Westphal–Lateral Septum Urocortin Pathway and Its Relationship to Alcohol Consumption
Bachtell, R. K., Weitemier, A. Z., Galvan-Rosas, A., Tsivkovskaia, N. O., Risinger, F. O., Phillips, T. J., Grahame, N. J., & Ryabinin, A. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02477.2003 · Cited by 107
Blacktop, J. M., Seubert, C., Baker, D. L., Ferda, N., Lee, G., Graf, E. N., & Mantsch, J. R. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1393-11.2011 · Cited by 104
Schmid, B., Blomeyer, D., Treutlein, J., Zimmermann, U. S., Buchmann, A. F., Schmidt, M. H., Esser, G., Rietschel, M., Banaschewski, T., Schumann, G., et al. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990290 · Cited by 103 · cited 5×
“Adolescent carriers of the A allele of the rs242938 Crhr1 SNP similarly reported more drinking when exposed to stress in some (Schmid et al., 2010) but not other (Blomeyer et al.”
BackgroundInfluentialCommon Genetic Origins for EEG, Alcoholism and Anxiety: The Role of CRH-BP
Enoch, M.-A., Shen, P.-H., Ducci, F., Yuan, Q., Liu, J., White, K. V., Albaugh, B., Hodgkinson, C. A., & Goldman, D. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003620 · Cited by 102
MPZP: A novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist
RICHARDSON, H., ZHAO, Y., Fekete, É. M., FUNK, C., Wirsching, P., Janda, K. D., Zorrilla, E. P., & Koob, G. F. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.10.008 · Cited by 101
Self-citationRyabinin, A. E., Galván-Rosas, A., Bachtell, R. K., & Risinger, F. O. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1284-y · Cited by 98
Fekete, É. M., Inoue, K., Zhao, Y., Rivier, J., Vale, W., Szűcs, A. L., Koob, G. F., & Zorrilla, E. P. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301214 · Cited by 94
Self-citationGrigoriadis, D. E., Liu, X. J., Vaughn, J., Palmer, S. F., True, C. D., Vale, W. W., Ling, N., & De Souza, E. B. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09341-1 · Cited by 93
Boyson, C. O., Miguel, T. T., Quadros, I. M., DeBold, J. F., & Miczek, K. A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2266-8 · Cited by 92
Urocortin 1 distribution in mouse brain is strain-dependent
Weitemier, A. Z., Tsivkovskaia, N. O., & Ryabinin, A. E. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.047 · Cited by 90
Francesconi, W., Berton, F., Repunte-Canonigo, V., Hagihara, K., Thurbon, D., Lekic, D., Specio, S. E., Greenwell, T. N., Chen, S. A., Rice, K. C., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5129-08.2009 · Cited by 90
Self-citationHo, S. P., Takahashi, L. K., Livanov, V., Spencer, K. R., Lesher, T., Maciag, C. M., Smith, M. A., Rohrbach, K. W., Hartig, P. R., & Arnerić, S. P. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00050-x · Cited by 89
Possible neural substrates of beer-craving in rats
Topple, A. N., Hunt, G. E., & McGregor, I. S. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00574-6 · Cited by 88
Functional CRH variation increases stress-induced alcohol consumption in primates
Barr, C. S., Dvoskin, R. L., Gupte, M., Sommer, W. H., Sun, H., Schwandt, M. L., Lindell, S. G., Kasckow, J., Suomi, S. J., Goldman, D. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902863106 · Cited by 88
Hansson, A. C., Cippitelli, A., Sommer, W. H., Ciccocioppo, R., & Heilig, M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00050.x · Cited by 88
Association of Low-Voltage Alpha EEG With a Subtype of Alcohol Use Disorders
Enoch, M.-A., White, K. V., Harris, C. R., Robin, R. W., Ross, J., Rohrbaugh, J. W., & Goldman, D. (1999) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-199908000-00004 · Cited by 87
Greenwell, T. N., Funk, C. K., Cottone, P., Richardson, H. N., Chen, S. A., Rice, K. C., Zorrilla, E. P., & Koob, G. F. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00142.x · Cited by 87 · cited 2×
“…2007; Gehlert et al., 2007; Gilpin et al., 2008; Richardson et al., 2008) as well as the increased intravenous self-administration of cocaine (Specio et al., 2008), nicotine (George et al., 2007), and heroin (Greenwell et al., 2009) in rats with a history of extended access to the drug of abuse.”
BackgroundSelf-citationRay, L. A. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01333.x · Cited by 86
Urocortin 1-containing neurons in the human Edinger-Westphal nucleus
Ryabinin, A. E., Tsivkovskaia, N. O., & Ryabinin, S. A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.042 · Cited by 86
Inoue, K., Valdez, G. R., Reyes, T. M., Reinhardt, L. E., Tabarin, A., Rivier, J., Vale, W., Sawchenko, P. E., Koob, G. F., & Zorrilla, E. P. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047712 · Cited by 86
Self-citationUmhau, J. C., Schwandt, M. L., Usala, J., Geyer, C., Singley, E., George, D. T., & Heilig, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.253 · Cited by 84
Cippitelli, A., Damadzic, R., Singley, E., Thorsell, A., Ciccocioppo, R., Eskay, R. L., & Heilig, M. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.10.016 · Cited by 84
Zhao, Y., Weiss, F., & Zorrilla, E. P. (2007) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00456.x · Cited by 84
Self-citationZhao, Y., Valdez, G. R., Fekete, É. M., Rivier, J., Vale, W. W., Rice, K. C., Weiss, F., & Zorrilla, E. P. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123208 · Cited by 84
Self-citationLodge, D. J., & Lawrence, A. J. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00793-5 · Cited by 76
The urocortin 1 neurocircuit: Ethanol-sensitivity and potential involvement in alcohol consumption
Ryabinin, A. E., & Weitemier, A. Z. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.04.007 · Cited by 76
Torres, O. V., Gentil, L. G., Natividad, L. A., Carcoba, L. M., & O’Dell, L. E. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00038 · Cited by 76
Bachtell, R. K., Weitemier, A. Z., & Ryabinin, A. E. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03594.x · Cited by 76
Anacker, A. M. J., Loftis, J. M., Kaur, S., & Ryabinin, A. E. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00234.x · Cited by 75
Alling, C., Balldin, J., Bokström, K., Gottfries, C. G., Karlsson, I., & Långström, G. (1982) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1982.tb06720.x · Cited by 75
Pickens, R. W., Hatsukami, D. K., Spicer, J. W., & Svikis, D. S. (1985) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1985.tb05744.x · Cited by 73
Gender in relation to relapse crisis situations, coping, and outcome among treated alcoholics
Annis, H. M., Sklar, S. M., & Moser, A. E. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(97)00024-5 · Cited by 72
Bachtell, R. K., Tsivkovskaia, N. O., & Ryabinin, A. E. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00174-4 · Cited by 71
Buffalari, D. M., Baldwin, C. K., Feltenstein, M. W., & See, R. E. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.08.020 · Cited by 71
Disruption of the CRF/CRF1 Receptor Stress System Exacerbates the Somatic Signs of Opiate Withdrawal
Papaleo, F., Kitchener, P., & Contarino, A. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.022 · Cited by 71
Kőrösi, A., Schotanus, S. M., Olivier, B., Roubos, E. W., & Kozicz, T. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.012 · Cited by 71
Chen, A. C. H., Manz, N., Tang, Y., Rangaswamy, M., Almasy, L., Kuperman, S., Nurnberger, J., O’Connor, S. J., Edenberg, H. J., Schuckit, M. A., et al. (2010) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01173.x · Cited by 68
Ataxia and c-Fos Expression in Mice Drinking Ethanol in a Limited Access Session
Sharpe, A. L., Tsivkovskaia, N. O., & Ryabinin, A. E. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000174746.64499.83 · Cited by 67
Molander, A., Vengeliene, V., Heilig, M. A., Wurst, W., Deussing, J. M., & Spanagel, R. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.297 · Cited by 67
Mossberg, D., Liljeberg, P., & Borg, S. (1985) · Alcohol · doi:10.1016/0741-8329(85)90133-8 · Cited by 66
Alcohol in excess: CRF1 receptors in the rat and mouse VTA and DRN
Hwa, L. S., DeBold, J. F., & Miczek, K. A. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2820-z · Cited by 66
Kaur, S., Li, J., Stenzel‐Poore, M. P., & Ryabinin, A. E. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01610.x · Cited by 63
Nelson, E. C., Agrawal, A., Pergadia, M. L., Wang, J. C., Whitfield, J. B., Saccone, F. S., Kern, J., Grant, J. D., Schrage, A. J., Rice, J. P., et al. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00181.x · Cited by 63
Giardino, W. J., & Ryabinin, A. E. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12076 · Cited by 63
Lesions of the Edinger-Westphal nucleus alter food and water consumption.
Weitemier, A. Z., & Ryabinin, A. E. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.5.1235 · Cited by 59
Bruijnzeel, A. W., Ford, J., Rogers, J. A., Scheick, S., Ji, Y., Bishnoi, M., & Alexander, J. C. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.12.001 · Cited by 59
Expression of c-Fos in Alko Alcohol Rats Responding for Ethanol in an Operant Paradigm
Weitemier, A. Z., Woerner, A. E., Bäckström, P., Hyytiä, P., & Ryabinin, A. E. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200105000-00011 · Cited by 58
Ryabinin, A. E., Yoneyama, N., Tanchuck, M. A., Mark, G. P., & Finn, D. A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.11.014 · Cited by 55
Koob, G. F., & Zorrilla, E. P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.213 · Cited by 55
Self-citationCloning and Structure of the Human Corticotrophin Releasing Factor-Binding Protein Gene (CRHBP)
Behan, D. P., Potter, E., Lewis, K. A., Jenkins, N. A., Copeland, N., Lowry, P. J., & Vale, W. W. (1993) · Genomics · doi:10.1006/geno.1993.1141 · Cited by 54
Briand, L. A., Gross, J. P., & Robinson, T. E. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.004 · Cited by 53
Disruption of the CRF2 Receptor Pathway Decreases the Somatic Expression of Opiate Withdrawal
Papaleo, F., Ghozland, S. G., Ingallinesi, M., Roberts, A. J., Koob, G. F., & Contarino, A. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.8 · Cited by 48
Self-citationNawata, Y., Kitaichi, K., & Yamamoto, T. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.01.003 · Cited by 48
ITF expression in mouse brain during acquisition of alcohol self-administration
Ryabinin, A. E., Bachtell, R. K., Freeman, P. A., & Risinger, F. O. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03251-0 · Cited by 46
Ayanwuyi, L. O., Carvajal, F., Lerma-Cabrera, J. M., Domi, E., Björk, K., Ubaldi, M., Heilig, M., Roberto, M., Ciccocioppo, R., & Cippitelli, A. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00023 · Cited by 44
Lê, A. D., Funk, D., Coen, K., Li, Z., & Shaham, Y. (2013) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00374.x · Cited by 42
Giardino, W. J., Cocking, D. L., Kaur, S., Cunningham, C. L., & Ryabinin, A. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026997 · Cited by 42
Simms, J. A., Nielsen, C. K., Li, R., & Bartlett, S. E. (2013) · Addiction Biology · doi:10.1111/adb.12024 · Cited by 40
CRF2 receptor-deficiency eliminates opiate withdrawal distress without impairing stress coping
Ingallinesi, M., Rouibi, K., Moine, C. L., Papaleo, F., & Contarino, A. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.119 · Cited by 39
Brown, Z. J., Kupferschmidt, D. A., & Erb, S. M. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2772-3 · Cited by 39
Interactions of Stress and CRF in Ethanol‐Withdrawal Induced Anxiety in Adolescent and Adult Rats
Wills, T. A., Knapp, D. J., Overstreet, D. H., & Breese, G. R. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01245.x · Cited by 38
Tucci, S., Cheeta, S., Seth, P., & File, S. E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1403-4 · Cited by 38
Bruijnzeel, A. W., Small, E., Pasek, T. M., & Yamada, H. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.02.043 · Cited by 37
Park, P. E., Vendruscolo, L. F., Schlosburg, J. E., Edwards, S., Schulteis, G., & Koob, G. F. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000308 · Cited by 37
Self-citationSpangler, E., Cote, D. M., Anacker, A. M. J., Mark, G. P., & Ryabinin, A. E. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.02.030 · Cited by 36
Knapp, D. J., Overstreet, D. H., Huang, M. M., Wills, T. A., Whitman, B. A., Angel, R. A., Sinnett, S. E., & Breese, G. R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2366-5 · Cited by 35
Pastor, R., Reed, C. L., Burkhart‐Kasch, S., Li, N., Sharpe, A. L., Coste, S. C., Stenzel‐Poore, M. P., & Phillips, T. J. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2284-6 · Cited by 35
Zorrilla, E. P., Wee, S., Zhao, Y., Specio, S. E., Boutrel, B., Koob, G. F., & Weiss, F. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00329.x · Cited by 34
Self-citationRibbe, K. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.100 · Cited by 34
Kupferschmidt, D. A., Lovejoy, D. A., Rotzinger, S., & Erb, S. M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01055.x · Cited by 33
Chamine, I., Spangler, E., Cannella, N., Sabino, V., Cottone, P., Ciccocioppo, R., Zorrilla, E. P., & Ryabinin, A. E. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01033.x · Cited by 32
Self-citationCentral urocortin 3 administration decreases limited-access ethanol intake in nondependent mice
Sharpe, A. L., & Phillips, T. J. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832f01ba · Cited by 31
Aydın, Ç., Oztan, O., & Isgor, C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.12.056 · Cited by 30
Turek, V. F., & Ryabinin, A. E. (2005) · Brain Research · doi:10.1016/j.brainres.2005.09.056 · Cited by 29
Kupferschmidt, D. A., Klas, P., & Erb, S. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01983.x · Cited by 28
Skelton, K. H., Gutman, D. A., Thrivikraman, K. V., Nemeroff, C. B., & Owens, M. J. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0713-3 · Cited by 28
García-Carmona, J. A., Almela, P., Baroja‐Mazo, A., Milanés, M. V., & Laorden, M. L. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2478-y · Cited by 25
Anxiolytic-Like Effects of Antisauvagine-30 in Mice Are Not Mediated by CRF2 Receptors
Zorrilla, E. P., Roberts, A. J., Rivier, J., & Koob, G. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063942 · Cited by 24
Self-citationA prospective study of stress and alcohol craving in heavy drinkers
Tartter, M. A., & Ray, L. A. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.007 · Cited by 23
Gysling, K. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.101 · Cited by 19
(1994) · Genomics · doi:10.1006/geno.1994.1047 · Cited by 15
Zywiak, W. H., Connors, G. J., Maisto, S. A., & Westerberg, V. S. (1996) · Addiction · doi:10.1080/09652149638854 · Cited by 9
Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse
Van Pett, K., Viau, V., Bittencourt, J. C., Chan, R. K. W., Li, H.-Y., Arias, C., Prins, G. S., Perrin, M., Vale, W., & Sawchenko, P. E. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001211)428:2<191::aid-cne1>3.0.co;2-u
S�nchez, M. M., Young, L. J., Plotsky, P. M., & Insel, T. R. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990607)408:3
Cited by
Clarke, T.-K., Adams, M. J., Davies, G., Howard, D. M., Hall, L. S., Padmanabhan, S., Murray, A. D., Smith, B. H., Campbell, A., Hayward, C., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.153 · Cited by 440
Sanchez-Roige, S., Palmer, A. A., Fontanillas, P., Elson, S. L., the 23andMe Research Team, T. S. U. D. W. G. O. T. P. G. C., Adams, M. J., Howard, D. M., Edenberg, H. J., Davies, G., Crist, R. C., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18040369 · Cited by 430
Wise, R. A., & Robble, M. A. (2020) · Annual Review of Psychology · doi:10.1146/annurev-psych-010418-103337 · Cited by 404
Keep off the grass? Cannabis, cognition and addiction
Curran, H. V., Freeman, T. P., Mokrysz, C., Lewis, D. A., Morgan, C. J. A., & Parsons, L. H. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.28 · Cited by 389
Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review
Siefried, K. J., Acheson, L. S., Lintzeris, N., & Ezard, N. (2020) · CNS Drugs · doi:10.1007/s40263-020-00711-x · Cited by 194
Metadata
- Authors
- Zorrilla, E. P., Logrip, M. L., & Koob, G. F.
- Venue
- Frontiers in Neuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 35
- Issue
- 2
- Pages
- 234-244
- ISSN
- 0091-3022 (ISSN-L)
- OpenAlex
- W2088468969
- Cited by
- 254
- References
- 199
- FWCI
- 13.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.